高级检索

LC-MS分析生物样品中肽类及蛋白类药物的技术问题及其解决方案

Common issues and counterplans on LC-MS analysis of peptides and proteins in bio-samples

  • 摘要: 肽类及蛋白类药物的理化性质较为特殊,其LC-MS分析方法与传统的化学药物相比,存在不少特殊性,在定量分析测定上也存在不少问题。这些问题包括:容器壁对肽类及蛋白的吸附作用、生物样品中肽类及蛋白易降解、生物样品基质中大量内源性肽类及蛋白对测定的干扰、极性较大在反相柱上不易保留、质谱分析肽类及蛋白时对离子源和质量分析器的要求以及内标不易寻找等。本文对液相色谱-质谱联用技术在肽类及蛋白类样品分析中的常见问题及其解决方法进行了综述。

     

    Abstract: The analytical methods for peptide and protein drugs in the bio-samples using liquid chromatography-mass spectrometry(LC-MS) are different from those for small molecular drugsQuantification of peptide and protein drugs is faced with many challenges because of their special physicochemical properties,such as the adsorption to solid surfaces,chemical unstable in the bio-samples,interference from endogenous substances,poor retention behaviors,special requirements on ionization sources,mass analyzers and internal standardsThis paper focuses on the common issues and counterplans on the LC-MS analysis of peptides and proteins in bio-samples.

     

/

返回文章
返回